Targovax receives Fast Track designation for ONCOS-102 in melanoma ...Middle East

OSLO, Norway, June 22, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immune-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that its lead clinical candidate ONCOS-102 has received Fast Track designation in...

Hence then, the article about targovax receives fast track designation for oncos 102 in melanoma was published today ( Tuesday 22/06/2021 - 08:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Targovax receives Fast Track designation for ONCOS-102 in melanoma )

Also on site :

• 7 Books To Read After 'Heated Rivalry,' According to a Librarian
• Anthropologie’s Sparkly $13 Pave Heart Stud Earrings Are Perfect for Everyday Wear and Spring Occasions
• Houthis join Middle East conflict